SCHEMBL17675111

SCHEMBL17675111

CC1CCN(c2ncccc2C(N)=O)C1(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 3/20 0.40
RECQL P46063 1/20 0.40
PARP1 P09874 3/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
OPRK1 P41145 4/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ROCK2 O75116 2/20 0.36
MYC P01106 1/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29192765 0.79 NNMT (0.34) PARP1ALDH1A1SMN1; SMN2
SCHEMBL28205881 0.78 KMT2A (0.44) KMT2AKDM4EPARP1DDB1CRBN
SCHEMBL29550897 0.78 KMT2A (0.44) KMT2AKDM4EPARP1DDB1CRBN
SCHEMBL29916381 0.78 KMT2A (0.44) KMT2AKDM4EPARP1DDB1CRBN
SCHEMBL17675120 0.78 KMT2A (0.44) KMT2AKDM4EPARP1DDB1CRBN
SCHEMBL29147335 0.76 CFTR (0.41)
SCHEMBL29146283 0.76 SCN9A (0.37) KMT2AMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL28715492 0.74 GFER (0.48) KMT2AKDM4EPARP1MEN1CYP1A2
SCHEMBL12220399 0.73 KMT2A (0.50) KMT2APARP1MEN1CYP1A2CYP3A4
SCHEMBL29534493 0.71 KIF18A (0.50) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 WO disclosed